Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iron Catalyzed Cross Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107827715A reveals a cost-effective Iron-catalyzed route for 2-hydroxyphenyl styryl ethers, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Patent CN102850319A reveals a cost-effective, high-yield route for Fingolimod intermediates, eliminating toxic solvents and expensive palladium catalysts for scalable manufacturing.
Patent CN105884677A reveals iron-catalyzed cross-coupling breakthrough. Delivers high-purity pharmaceutical intermediates with substantial cost reduction and supply chain reliability.
Patent CN106660928A reveals a novel two-step iron-catalyzed route for grapevine moth pheromone. Achieve high purity and substantial cost reduction in pheromone manufacturing.
Patent CN110372544B details a cost-effective iron-titanium catalytic system for biaryl synthesis, offering significant supply chain stability and reduced environmental impact.
Patent CN112479993A details a cost-effective iron-catalyzed synthesis for KRAS inhibitor intermediates, offering significant supply chain and purity advantages for API manufacturers.